Sirkadiyen Ritim Düzenleyiciler, Işık ve Göz Hastalıkları
Özet
Sirkadiyen ritim, siyanobakterilerden insanlara kadar geniş bir yelpazede tanımlanan, yaklaşık 24 saatlik periyotlarla kendini tekrar eden endojen biyolojik süreçleri ifade etmektedir. Memelilerde bu sistemin ana hiyerarşik düzenleyicisi suprakiyazmatik nükleus (SKN) olup, periferik doku ve organlardaki saatleri nöronal ve hormonal yollar aracılığıyla senkronize eder. Sirkadiyen zamanlamanın ayarlanmasında en baskın dış uyaran ışık iken, temel endokrin çıktı sinyali ise gece sentezi artan melatonin hormonudur. Başta oküler yüzey ve retina olmak üzere gözün birçok anatomik bölümünde melatonin reseptörleri bulunmakta ve bu döngü oküler fizyolojinin sürdürülmesinde kritik roller oynamaktadır. Zamanlama sistemindeki bozulmalar; kuru göz, korneal yara iyileşmesinde gecikme, glokom, miyopi, katarakt ve diyabetik retinopati gibi çeşitli göz hastalıklarının patogeneziyle yakından ilişkilidir. Örneğin glokom hastalarında gece göz içi basıncı dalgalanmaları ve melatonine karşı olası bir direnç gözlenirken, açık havada yüksek ışığa maruz kalmanın dopamin ve melatonin salınımını etkileyerek miyopi gelişimini azalttığı saptanmıştır. Sonuç olarak, göz hastalıklarının tanı ve tedavisinde sirkadiyen ritmin 24 saatlik takibi ve melatonin analoglarının terapötik kullanımı, klinik yaklaşımlar için güçlü gelecek hedefleri sunmaktadır.
Circadian rhythms represent endogenous biological processes with a period of approximately 24 hours, observed across a wide spectrum from cyanobacteria to humans. In mammals, the primary hierarchical pacemaker of this system is the suprachiasmatic nucleus (SCN), which synchronizes clocks in peripheral tissues and organs through neuronal and hormonal pathways. While light is the most dominant environmental cue in adjusting circadian timing, melatonin, whose synthesis increases at night, serves as the fundamental endocrine output signal. Melatonin receptors are present in many anatomical sections of the eye, particularly the ocular surface and retina, and this cycle plays critical roles in maintaining ocular physiology. Disruptions in the timing system are closely associated with the pathogenesis of various ocular diseases, such as dry eye, delayed corneal wound healing, glaucoma, myopia, cataracts, and diabetic retinopathy. For instance, while glaucoma patients exhibit nocturnal intraocular pressure fluctuations and potential resistance to melatonin, exposure to high outdoor light has been found to reduce myopia development by influencing dopamine and melatonin release. Consequently, the 24-hour monitoring of circadian rhythms and the therapeutic use of melatonin analogues in the diagnosis and treatment of ocular diseases offer potent future targets for clinical approaches.
Referanslar
Dassonville PF. Biorhythm & Chronobiology. Current Trends in Biomedical Engineering & Biosciences. 2018;22:14(4).
Muraro NI, Ceriani MF. Circadian rhythms. Behavioral Genetics of the Fly (Drosophila Melanogaster). 2014;104–15.
Zhu Q, Belden WJ. Molecular Regulation of Circadian Chromatin. Journal of Molecular Biology. 2020;432(12):3466–82.
Pett JP, Westermark PO, Herzel H. Simple Kinetic Models in Molecular Chronobiology. Methods in Molecular Biology. 2021;2130:87–100.
Turek FW, Vitaterna MH. Molecular neurobiology of circadian rhythms. Handbook of Clinical Neurology. 2011;99(C):951–61.
Dunlap JC. Molecular Bases for Circadian Clocks. Cell. 1999;96(2):271–90.
Rosbash M. Molecular control of circadian rhythms. Current Opinion in Genetics & Development. 1995;5(5):662–8.
Huang R-C. Molecular Mechanisms in the Circadian Rhythm. eLS. 2020;1:128–35.
Swaab DF (Dick F. Progress in brain research Volume 93, The human hypothalamus in health and disease: proceedings of the 17th International Summer School of Brain Research : held at the auditorium of the University of Amsterdam, the Netherlands, 26-30 August 1991. 1992;481.
Young R. Mind, brain, and adaptation in the nineteenth century: cerebral localization and its biological context from Gall to Ferrier. 1990
Critchley M, Brit med Jt F. Neurology’s debt to F. J. Gall (1758-1828). British Medical Journal. 1965;2(5465):775.
Pittendrigh CS. Temporal organization: reflections of a Darwinian clock-watcher. Annu Rev Physiol. 1993;55:17–54.
Schaap J, Pennartz C, Meijer JH. Electrophysiology of the circadian pacemaker in mammals. Chronobiology International. 2009;20(2):171-188.
Yamazaki S, Numano R, Abe M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science. 2000;288(5466):682–5.
Dibner C, Schibler U, Albrecht U. The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks. Annual Review of Physiology. 2010;72:517–49.
Scheer FAJL, ter Horst GJ, van der Vliet J, Buijs RM. Physiological and anatomic evidence for regulation of the heart by suprachiasmatic nucleus in rats. American Journal of Physiology - Heart and Circulatory Physiology. 2001; 280(3):H1391-9.
Buijs RM, Chun SJ, Niijima A, et al. Parasympathetic and Sympathetic Control of the Pancreas: A Role for the Suprachiasmatic Nucleus and Other Hypothalamic Centers That Are Involved in the Regulation of Food Intake. J Comp Neurol. 2001;431:405–23.
la Fleur SE, Kalsbeek A, Wortel J, et al. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res. 2000;871(1):50–6.
Klein DC, Smoot R, Weller JL, et al. Lesions of the paraventricular nucleus area of the hypothalamus disrupt the suprachiasmatic→ spinal cord circuit in the melatonin rhythm generating system. Brain Research Bulletin. 1983;10(5):647–52.
Kalsbeek A, Garidou ML, Palm IF, et al. Melatonin sees the light: blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur J Neurosci. 2000;12(9):3146–54.
Clokie SJH, Lau P, Kim HH, et al. MicroRNAs in the Pineal Gland: miR-483 Regulates Melatonın Synthesıs By Targetıng Arylalkylamıne N-Acetyltransferase. The Journal of Biological Chemistry. 2012;287(30):25312.
Perreau-Lenz S, Kalsbeek A, Pévet P, et al. Glutamatergic clock output stimulates melatonin synthesis at night. Eur J Neurosci. 2004;19(2):318–24.
Jamshed H, Beyl RA, Manna DLD, et al. Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans. Nutrients. 2019;11(6).
de Alencar Silva BS, Uzeloto JS, Lira FS, et al. Exercise as a Peripheral Circadian Clock Resynchronizer in Vascular and Skeletal Muscle Aging. Int J Environ Res Public Health. 2021;18(24).
Pévet P, Agez L, Bothorel B, Saboureau M, et al. Melatonin in the multi-oscillatory mammalian circadian world. Chronobiol Int. 2006;23(1–2):39–51.
Rensing L, Ruoff P. Temperature effect on entrainment, phase shifting, and amplitude of circadian clocks and its molecular bases. Chronobiol Int. 2002;19(5):807–64.
Refinetti R. Comparison of light, food, and temperature as environmental synchronizers of the circadian rhythm of activity in mice. J Physiol Sci. 2015;65(4):359–66.
Huang RC. The discoveries of molecular mechanisms for the circadian rhythm: The 2017 Nobel Prize in Physiology or Medicine. Biomed J. 2018;41(1):5–8.
Dunlap JC. Molecular bases for circadian clocks. Cell. 1999;96(2):271–90.
Koike N, Yoo SH, Huang HC, et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science. 2012;338(6105):349–54.
Forman BM, Chen J, Blumberg B, et al. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol. 1994;8(9):1253–61.
Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet. 2006;38(3):369–74.
Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418(6901):935–41.
Moore RY. Entrainment pathways and the functional organization of the circadian system. Prog Brain Res. 1996;111:103–19.
Panda S, Provencio I, Tu DC, et al. Melanopsin is required for non-image-forming photic responses in blind mice. Science. 2003;301(5632):525–7.
Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070–3.
Brown RL, Robinson PR. Melanopsin--shedding light on the elusive circadian photopigment. Chronobiol Int. 2004;21(2):189–204.
Cahill GM, Menaker M. Responses of the suprachiasmatic nucleus to retinohypothalamic tract volleys in a slice preparation of the mouse hypothalamus. Brain Res. 1989;479(1):65–75.
Shigeyoshi Y, Taguchi K, Yamamoto S, et al. Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell. 1997;91(7):1043–53.
Guido ME, Goguen D, de Guido L, et al. Circadian and photic regulation of immediate-early gene expression in the hamster suprachiasmatic nucleus. Neuroscience.1999;90(2):555–71.
Rusak B, Robertson HA, Wisden W, et al. Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus. Science. 1990;248(4960):1237–40.
Harmar AJ. An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei. J Neuroendocrinol. 2003;15(4):335–8.
Harmar AJ, Marston HM, Shen S, et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell. 2002;109(4):497–508.
Redlin U. Neural basis and biological function of masking by light in mammals: suppression of melatonin and locomotor activity. Chronobiol Int. 2001;18(5):737–58.
Mrosovsky N. Masking: history, definitions, and measurement. Chronobiol Int. 1999;16(4):415–29.
Redlin U, Mrosovsky N. Masking by light in hamsters with SCN lesions. J Comp Physiol A. 1999;184(4):439–48.
Vitaterna MH, Selby CP, Todo T, et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA. 1999;96(21):12114–9.
Cheng MY, Bullock CM, Li C, et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature. 2002;417(6887):405–10.
Cheng MY, Bittman EL, Hattar S, et al. Regulation of prokineticin 2 expression by light and the circadian clock. BMC Neuroscience. 2005;6:17.
Tähkämö L, Partonen T, Pesonen AK. Systematic review of light exposure impact on human circadian rhythm. Chronobiol Int. 2019;36(2):151-170.
Yamazaki S, Numano R, Abe M, et al. Resetting Central and Peripheral Circadian Oscillators in Transgenic Rats. Science (1979). 2000;288(5466):682–5.
Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 1972;42(1):201–6.
Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod. 1998;3(1):13–22.
Aimoto T, Rohde BH, Chiou GCY, et al. N-acetyltransferase activity and melatonin level in the eyes of glaucomatous chickens. J Ocul Pharmacol. 1985;1(2):149–60.
Abe M, Itoh MT, Miyata M, et al. Circadian rhythm of serotonin N -acetyltransferase activity in rat lens. Exp Eye Res. 2000;70(6):805–8.
Klein DC, Coon SL, Roseboom PH, et al. The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Progress in Hormone Research. 1997;52:307–57.
Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA. 1995;92(19):8734.
Crooke A, Guzman-Aranguez A, Mediero A, et al. Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. Curr Eye Res. 2015;40(1):56–65.
Pintor J, Carracedo G, Mediero A, et al. Melatonin Increases the Rate of Corneal Re–epithelialisation in New Zealand White Rabbits | IOVS | ARVO Journals. Investigative Ophthalmology & Visual Science. 2005;46(13):2152.
Ayaki M, Tachi N, Hashimoto Y, et al. Diurnal variation of human tear meniscus volume measured with tear strip meniscometry self-examination. PLoS ONE. 2019; 1:14(4).
Carracedo G, Carpena C, Concepción P, et al. Presence of melatonin in human tears. Journal of Optometry. 2017;10(1):3.
Lavker RM, Dong G, Cheng SZ, et al. Relative proliferative rates of limbal and corneal epithelia. Implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing keratinocytes. Investigative Ophthalmology & Visual Science. 1991;32(6):1864–75.
Crespo-Moral M, Alkozi HA, López-García A, et al. Melatonin receptors are present in the porcine ocular surface and are involved in ex vivo corneal wound healing. Investigative Ophthalmology & Visual Science. 2018;59(9):4371.
Quaranta L, Katsanos A, Russo A, et al. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013 Jan;58(1):26–41.
McCannel C, Koskela T, Brubaker RF. Topical flurbiprofen pretreatment does not block apraclonidine’s effect on aqueous flow in humans. Arch Ophthalmol. 1991;109(6):810–1.
Larsson LI, Rettig ES, Brubaker RF. Aqueous flow in open-angle glaucoma. Arch Ophthalmol. 1995;113(3):283–6.
Alkozi HA, Navarro G, Franco R, et al. Melatonin and the control of intraocular pressure. Prog Retin Eye Res. 2020;1:75.
Liu JHK, Zhang X, Kripke DF, et al. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44(4):1586–90.
Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol. 1999;43 Suppl 1(6 SUPPL.).
Leske MC, Heijl A, Hyman L, et al. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106(11):2144–53.
Ma XP, Shen MY, Shen GL, et al. Melatonin concentrations in serum of primary glaucoma patients. Int J Ophthalmol. 2018;11(8):1337–41.
Martínez-Águila A, Fonseca B, Bergua A, et al. Melatonin analogue agomelatine reduces rabbit’s intraocular pressure in normotensive and hypertensive conditions. Eur J Pharmacol. 2013;701(1–3):213–7.
Carracedo-Rodríguez G, Martínez-Águila A, Rodriguez-Pomar C, et al. Effect of nutritional supplement based on melatonin on the intraocular pressure in normotensive subjects. Int Ophthalmol. 2020;40(2):419–22.
Huete-Toral F, Crooke A, Martínez-Águila A, et al. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther. 2015;352(1):119–28.
Chakraborty R, Read SA, Collins MJ. Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics. Invest Ophthalmol Vis Sci. 2011;52(8):5121–9.
Weiss S, Schaeffel F. Diurnal growth rhythms in the chicken eye: relation to myopia development and retinal dopamine levels. J Comp Physiol A. 1993;172(3):263–70.
Stone RA, Cohen Y, McGlinn AM, et al. Development of Experimental Myopia in Chicks in a Natural Environment. Invest Ophthalmol Vis Sci. 2016;57(11):4779–89.
Wu PC, Chen CT, Lin KK, et al. Myopia Prevention and Outdoor Light Intensity in a School-Based Cluster Randomized Trial. Ophthalmology. 2018;125(8):1239–50.
Zhang L, Qu X. The Effects of High Lighting on the Development of Form-Deprivation Myopia in Guinea Pigs. Invest Ophthalmol Vis Sci. 2019;60(13):4319–27.
Chakraborty R, Micic G, Thorley L, et al. Myopia, or near-sightedness, is associated with delayed melatonin circadian timing and lower melatonin output in young adult humans. Sleep. 2021;1:44(3).
Wang F, Zhou J, Lu Y, et al. Effects of 530 nm green light on refractive status, melatonin, MT1 receptor, and melanopsin in the guinea pig. Current Eye Research, 2011;36(2), 103-111.
Beebe DC, Holekamp NM, Shui YB. Oxidative damage and the prevention of age-related cataracts. Ophthalmic Res. 2010;44(3):155–65.
Alkozi HA, Wang X, Perez de Lara MJ, et al. Presence of melanopsin in human crystalline lens epithelial cells and its role in melatonin synthesis. Exp Eye Res. 2017;154:168–76.
Wiechmann AF, Smith AR. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina. Brain Res Mol Brain Res. 2001;91(1–2):104–11.
Chang CC, Huang TY, Chen HY, et al. Protective Effect of Melatonin against Oxidative Stress-Induced Apoptosis and Enhanced Autophagy in Human Retinal Pigment Epithelium Cells. Oxid Med Cell Longev. 2018;2018.
Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5(1):655–60.
Jiang T, Chang Q, Cai J, et al. Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy. Oxid Med Cell Longev. 2016;2016.
